Botulism Antitoxin: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 April 2024

  • curprev 18:1518:15, 30 April 2024‎ Alara E. Dagsali talk contribs‎ 18,011 bytes +3‎ No edit summary
  • curprev 18:1418:14, 30 April 2024‎ Alara E. Dagsali talk contribs‎ 18,008 bytes +18,008‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |genericName=BAT |aOrAn=a |indicationType=treatment |indication=BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] is a mixture of immune globulin fragments indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients. |adverseReactions=The most common adverse reactions obse..."
Retrieved from "https://www.wikidoc.org/index.php/Botulism_Antitoxin"